Russell Investments Group Ltd. raised its position in Itron, Inc. (NASDAQ:ITRI - Free Report) by 808.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,922 shares of the scientific and technical instruments company's stock after purchasing an additional 27,519 shares during the quarter. Russell Investments Group Ltd. owned 0.07% of Itron worth $3,239,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of ITRI. Janney Montgomery Scott LLC raised its holdings in shares of Itron by 0.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company's stock valued at $1,759,000 after buying an additional 121 shares during the period. CoreCap Advisors LLC grew its position in Itron by 25.5% in the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after acquiring an additional 125 shares in the last quarter. Captrust Financial Advisors increased its stake in Itron by 6.3% during the fourth quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock worth $233,000 after purchasing an additional 128 shares during the period. HighTower Advisors LLC lifted its position in shares of Itron by 2.0% during the first quarter. HighTower Advisors LLC now owns 7,501 shares of the scientific and technical instruments company's stock worth $786,000 after purchasing an additional 146 shares in the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC boosted its stake in shares of Itron by 7.3% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company's stock valued at $246,000 after purchasing an additional 160 shares during the period. 96.19% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on ITRI. JPMorgan Chase & Co. raised Itron from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $128.00 to $145.00 in a research report on Thursday, July 31st. Wall Street Zen upgraded Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. TD Cowen increased their price target on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, June 20th. Stephens set a $130.00 price objective on Itron in a research report on Monday, August 4th. Finally, Roth Capital upped their target price on shares of Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Eleven investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $136.25.
Read Our Latest Stock Report on Itron
Itron Trading Up 2.8%
NASDAQ:ITRI opened at $126.83 on Friday. The stock has a 50-day simple moving average of $130.57 and a 200-day simple moving average of $115.21. The stock has a market cap of $5.80 billion, a P/E ratio of 21.68, a P/E/G ratio of 0.69 and a beta of 1.35. Itron, Inc. has a 1 year low of $90.11 and a 1 year high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04.
Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.29. The business had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business's quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the company earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.
Insider Buying and Selling at Itron
In related news, SVP Christopher E. Ware sold 339 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total value of $38,968.05. Following the completion of the sale, the senior vice president directly owned 19,468 shares of the company's stock, valued at $2,237,846.60. The trade was a 1.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Donald L. Reeves III sold 529 shares of Itron stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total value of $60,808.55. Following the sale, the senior vice president owned 20,151 shares in the company, valued at $2,316,357.45. This trade represents a 2.56% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,755 shares of company stock worth $1,879,397. 1.45% of the stock is owned by insiders.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.